Why Hypotho
Why sponsors chooseHypotho Research.
Specialised focus, scientific depth and regulatory fluency — the reasons programmes trust us with their most critical imaging questions.
Our Advantages
Six reasons to partner with us.
Pioneers in India
The first and only corporate entity providing commercial pharmaco-scintigraphy across India — API, formulation, animal, ex-vivo and in-vitro studies.
Proprietary Labelling
Inventors of surface labelling and DPI & MDI labelling techniques recognised at a global level.
Unmatched Experience
20 years of individual and 100 years of cumulative experience in radiolabelling and scintigraphy clinical trials.
Broad Labelling Competence
Labelling of APIs, biologics, proteins, vaccines, macromolecules, nano-drugs, cells and every major formulation type.
Robust Quality Control
Rigorous, need-based quality control built into every study and radiolabelling batch.
Full Clinical Solution
Expert doctors and coordinators deliver protocol design through to ICH-GCP compliant reports and regulatory submission.
0+
Years Cumulative Experience
0+
Years Individual Expertise
0
Product Categories
0%
In-house Radiolabelling
Start a Conversation
See your molecule in motion.
Partner with our scientists to design an imaging study that answers your most critical development question.